Leading Interoperability Company Demonstrates Commitment to Interoperability with Two Healthcare Technology Vendor Partnerships
Rhapsody, a global leader in healthcare data interoperability, today announced that as part of its effort to create a truly interoperable ecosystem in healthcare, it has partnered with two healthcare technology vendors: BioIntelliSense and HICG. These companies are the latest to leverage Rhapsody’s industry leading interoperability engines, Rhapsody and Corepoint, to streamline the complexities of healthcare data.
BioIntelliSense, a continuous health monitoring and clinical intelligence company, is using Corepoint One as its data mapping and translation engine for seamless API-level exchange with third party enterprise platforms; such as Electronic Medical Record systems, Remote Patient Monitoring applications and Virtual Care solutions. BioIntelliSense’s Data-as-a-Service (DaaS) platform offers the flagship FDA-cleared BioSticker™ and the new BioButton™ medical grade disposable device, for continuous temperature and vital sign monitoring for a remarkable 90 days. “Rhapsody’s market leading data integration engine is a proven and critical enabler in accelerating remote patient monitoring deployments with our payor, provider, clinical trial and enterprise employer clients,” said James Mault, MD, CEO of BioIntelliSense.
Healthcare Integration Consulting Group (HICG), a healthcare consulting group, is recommending Rhapsody to its hospital customers that are looking for a reputable integration engine. “Rhapsody’s Best in KLAS® integration engines help our hospital customers improve data sharing while enhancing workflow – mission critical capabilities in today’s dynamic healthcare environment,” said Frank Restaino, Founder of HICG. Rhapsody is a trusted partner and gives our hospitals the tools they need to solve the critical interoperability challenges of today while futureproofing against those of tomorrow.”
“When we relaunched the company in February, our goal was to create a truly interconnected healthcare ecosystem – and we knew we couldn’t do that entirely on our own,” said Erkan Akyuz, president and CEO of Rhapsody. “We set out to partner with market leaders and bring all the best and brightest minds in healthcare technology together to solve interoperability, and today’s announcement confirms that commitment. We are proud of the wide-range of partners that we currently have and we extend an invitation to other HIT vendors who share our vision.”
Vendors interested in working with Rhapsody can reach out here.
About BioIntelliSense: BioIntelliSense is ushering in a new era of continuous health monitoring and clinical intelligence for Remote Patient Monitoring (RPM). Its medical-grade Data-as-a-Service (DaaS) platform seamlessly captures multi-parameter vital signs, physiological biometrics and symptomatic events through an effortless patient experience. The FDA-cleared BioSticker™ and BioButton™ devices make remote monitoring and early detection simple. Through the platform’s advanced analytics, clinicians will now have access to high-resolution patient trending and reporting to enable medical grade care at home.
About Healthcare Integration Consulting Group (HICG): Formed by leading healthcare integration architects and developers, HICG offers exceptional value and return on investment for your internal and external application integration projects. Our company principals have, collectively, over 60 years of real-world healthcare integration experience across a broad spectrum of inpatient, departmental and EMR applications using a variety of integration middleware solutions and communication methods.
